Pharmacometabolomics: Implications for Clinical Pharmacology

May 29, 2019 (Noon–1 p.m. ET)


Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB), Best Pharmaceuticals for Children Act, NICHD




In this webinar, Richard Weinshilboum, M.D., will outline the science underlying the application of metabolomics to study drug response. He also will provide specific examples of the use of metabolomics to guide and inform multiple “-omics” disciplines as applied to precision medicine. 

Dr. Weinshilboum will focus on the following:

  • Introducing the techniques used in metabolomics as applied to clinical pharmacology
  • Providing examples of the application of metabolomics to drug response phenotypes
  • Outlining the use of metabolomic data to “guide” or “inform” genomic studies

Dr. Weinshilboum directs the pharmacogenomics program of the Mayo Center for Individualized Medicine and is co-principal investigator of the longstanding NIH Pharmacogenomics Research Network Center at the Mayo Clinic.


George Giacoia, OPPTB, NICHD
Phone: 301–496–5589

Please note: Views expressed during NICHD-sponsored events do not necessarily reflect the opinions or the official positions of NICHD, NIH, or HHS.
top of pageBACK TO TOP